Atlas Trials

Tolerability and Efficacy of AM and PM Once Daily Dosing With Extended-release Guanfacine Hydrochloride in Children 6-12 With Attention-Deficit/Hyperactivity Disorder (ADHD) (The ADHD Tempo Study)

Clinical trial NCT00997984 · COMPLETED

Trial details

NCT number
NCT00997984
Sponsor
Shire
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Attention-Deficit/Hyperactivity Disorder
Start date
2009-11-17
Primary completion
2010-10-09
Enrollment
340

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.